156 related articles for article (PubMed ID: 15981111)
1. Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma.
Palmieri C; Brock C; Newlands ES
J Neurooncol; 2005 Jun; 73(2):185. PubMed ID: 15981111
[No Abstract] [Full Text] [Related]
2. NICE verdict on Temozolomide: where next?
Brada M
Br J Cancer; 2002 Feb; 86(4):499-500. PubMed ID: 11870526
[No Abstract] [Full Text] [Related]
3. Temozolomide. A new option for high-grade astrocytomas.
Schwenka J; Ignoffo RJ
Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
[No Abstract] [Full Text] [Related]
4. Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.
Kourelis TV; Buckner JC; Gangat N; Patnaik MM
Am J Hematol; 2015 Sep; 90(9):E183-4. PubMed ID: 26010271
[No Abstract] [Full Text] [Related]
5. Temozolomide for refractory anaplastic astrocytoma.
Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
[No Abstract] [Full Text] [Related]
6. [Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse--a phase II clinical study].
Nishikawa R; Shibui S; Maruno M; Sugiyama K; Sato S; Fujimaki T; Takahashi H; Wakabayashi T; Takahashi J; Kochi M; Nakamura H; Sawamura Y; Ikeda J; Hori T; Aoki T; Matsutani M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1279-85. PubMed ID: 16969025
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide-induced flare in high-grade gliomas: a new clinical entity.
Rosenthal MA; Ashley DL; Cher L
Intern Med J; 2002 Jul; 32(7):346-8. PubMed ID: 12088355
[TBL] [Abstract][Full Text] [Related]
8. Disseminated salmonellosis in a patient treated with temozolomide.
Georgescu G; Isola IM; Youssef S; Adachi J; Rolston K
J Infect; 2008 Nov; 57(5):414-5. PubMed ID: 18715650
[TBL] [Abstract][Full Text] [Related]
9. Oral temozolomide approved for refractory brain tumor.
Miller JL
Am J Health Syst Pharm; 1999 Oct; 56(19):1910. PubMed ID: 10554903
[No Abstract] [Full Text] [Related]
10. 10 questions about temozolomide and the treatment of brain tumors.
Pruitt AA; Rosenfeld MR
Neurologist; 2005 Nov; 11(6):362-5. PubMed ID: 16286879
[No Abstract] [Full Text] [Related]
11. Urticarial hypersensitivity reaction caused by temozolomide.
Pothiawala S; Hsu MY; Yang C; Kesari S; Ibrahimi OA
J Drugs Dermatol; 2010 Sep; 9(9):1142-4. PubMed ID: 20865848
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.
Combs SE; Nagy M; Edler L; Rausch R; Bischof M; Welzel T; Debus J; Schulz-Ertner D
Radiother Oncol; 2008 Aug; 88(2):177-82. PubMed ID: 18395280
[TBL] [Abstract][Full Text] [Related]
15. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
[No Abstract] [Full Text] [Related]
16. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
Momota H; Narita Y; Miyakita Y; Hosono A; Makimoto A; Shibui S
Pediatr Blood Cancer; 2010 Sep; 55(3):577-9. PubMed ID: 20658636
[TBL] [Abstract][Full Text] [Related]
17. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
18. Higher dosing of temozolomide? Regression of an anaplastic oligoastrocytoma over more than three years.
Koch D; Wick W
J Neurooncol; 2006 Apr; 77(2):219-20. PubMed ID: 16292485
[No Abstract] [Full Text] [Related]
19. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.
Su YW; Chang MC; Chiang MF; Hsieh RK
J Neurooncol; 2005 Feb; 71(3):315-8. PubMed ID: 15735923
[TBL] [Abstract][Full Text] [Related]
20. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
